185 related articles for article (PubMed ID: 34516990)
1. Lipophilic Salts and Lipid-Based Formulations for Bridging the Food Effect Gap of Venetoclax.
Koehl NJ; Henze LJ; Holm R; Kuentz M; Keating JJ; De Vijlder T; Marx A; Griffin BT
J Pharm Sci; 2022 Jan; 111(1):164-174. PubMed ID: 34516990
[TBL] [Abstract][Full Text] [Related]
2. Rationalizing Counterion Selection for the Development of Lipophilic Salts: A Case Study with Venetoclax.
Ryan CD; Griffin BT; O'Shea JP
Mol Pharm; 2024 Jun; 21(6):2981-2992. PubMed ID: 38703358
[TBL] [Abstract][Full Text] [Related]
3. Enabling superior drug loading in lipid-based formulations with lipophilic salts for a brick dust molecule: Exploration of lipophilic counterions and in vitro-in vivo evaluation.
Sirvi A; Jadhav K; Sangamwar AT
Int J Pharm; 2024 May; 656():124108. PubMed ID: 38604540
[TBL] [Abstract][Full Text] [Related]
4. Enhancing the Oral Absorption of Kinase Inhibitors Using Lipophilic Salts and Lipid-Based Formulations.
Williams HD; Ford L; Han S; Tangso KJ; Lim S; Shackleford DM; Vodak DT; Benameur H; Pouton CW; Scammells PJ; Porter CJH
Mol Pharm; 2018 Dec; 15(12):5678-5696. PubMed ID: 30376336
[TBL] [Abstract][Full Text] [Related]
5.
Koehl NJ; Henze LJ; Bennett-Lenane H; Faisal W; Price DJ; Holm R; Kuentz M; Griffin BT
Mol Pharm; 2021 Jun; 18(6):2174-2188. PubMed ID: 33890794
[TBL] [Abstract][Full Text] [Related]
6. Lipophilic salts of poorly soluble compounds to enable high-dose lipidic SEDDS formulations in drug discovery.
Morgen M; Saxena A; Chen XQ; Miller W; Nkansah R; Goodwin A; Cape J; Haskell R; Su C; Gudmundsson O; Hageman M; Kumar A; Chowan GS; Rao A; Holenarsipur VK
Eur J Pharm Biopharm; 2017 Aug; 117():212-223. PubMed ID: 28438550
[TBL] [Abstract][Full Text] [Related]
7. Lipophilic Salts and Lipid-Based Formulations: Enhancing the Oral Delivery of Octreotide.
Li P; Ford L; Haque S; McInerney MP; Williams HD; Scammells PJ; Thompson PE; Jannin V; Porter CJH; Benameur H; Pouton CW
Pharm Res; 2021 Jun; 38(6):1125-1137. PubMed ID: 34100217
[TBL] [Abstract][Full Text] [Related]
8. Unlocking the full potential of lipid-based formulations using lipophilic salt/ionic liquid forms.
Williams HD; Ford L; Igonin A; Shan Z; Botti P; Morgen MM; Hu G; Pouton CW; Scammells PJ; Porter CJH; Benameur H
Adv Drug Deliv Rev; 2019 Mar; 142():75-90. PubMed ID: 31150666
[TBL] [Abstract][Full Text] [Related]
9. Utilization of Lipophilic Salt and Phospholipid Complex in Lipid-Based Formulations to Modulate Drug Loading and Oral Bioavailability of Pazopanib.
Jadhav K; Sirvi A; Janjal A; Kashyap MC; Sangamwar AT
AAPS PharmSciTech; 2024 Mar; 25(3):59. PubMed ID: 38472682
[TBL] [Abstract][Full Text] [Related]
10. Transformation of poorly water-soluble drugs into lipophilic ionic liquids enhances oral drug exposure from lipid based formulations.
Sahbaz Y; Williams HD; Nguyen TH; Saunders J; Ford L; Charman SA; Scammells PJ; Porter CJ
Mol Pharm; 2015 Jun; 12(6):1980-91. PubMed ID: 25905624
[TBL] [Abstract][Full Text] [Related]
11. Ionic Liquid Forms of the Antimalarial Lumefantrine in Combination with LFCS Type IIIB Lipid-Based Formulations Preferentially Increase Lipid Solubility, In Vitro Solubilization Behavior and In Vivo Exposure.
Tay E; Nguyen TH; Ford L; Williams HD; Benameur H; Scammells PJ; Porter CJH
Pharmaceutics; 2019 Dec; 12(1):. PubMed ID: 31877828
[TBL] [Abstract][Full Text] [Related]
12. Transformation of Biopharmaceutical Classification System Class I and III Drugs Into Ionic Liquids and Lipophilic Salts for Enhanced Developability Using Lipid Formulations.
Williams HD; Ford L; Lim S; Han S; Baumann J; Sullivan H; Vodak D; Igonin A; Benameur H; Pouton CW; Scammells PJ; Porter CJH
J Pharm Sci; 2018 Jan; 107(1):203-216. PubMed ID: 28549907
[TBL] [Abstract][Full Text] [Related]
13. Supersaturated Lipid-Based Formulations to Enhance the Oral Bioavailability of Venetoclax.
Koehl NJ; Henze LJ; Kuentz M; Holm R; Griffin BT
Pharmaceutics; 2020 Jun; 12(6):. PubMed ID: 32570753
[TBL] [Abstract][Full Text] [Related]
14. A Rundown Through Various Methods Used in the Formulation of Solid Self-Emulsifying Drug Delivery Systems (S-SEDDS).
Almeida SRD; Tippavajhala VK
AAPS PharmSciTech; 2019 Oct; 20(8):323. PubMed ID: 31654184
[TBL] [Abstract][Full Text] [Related]
15. Ionic Liquid Forms of Weakly Acidic Drugs in Oral Lipid Formulations: Preparation, Characterization, in Vitro Digestion, and in Vivo Absorption Studies.
Sahbaz Y; Nguyen TH; Ford L; McEvoy CL; Williams HD; Scammells PJ; Porter CJH
Mol Pharm; 2017 Nov; 14(11):3669-3683. PubMed ID: 28954512
[TBL] [Abstract][Full Text] [Related]
16. Improving solubility and oral bioavailability of a novel antimalarial prodrug: comparing spray-dried dispersions with self-emulsifying drug delivery systems.
Potharaju S; Mutyam SK; Liu M; Green C; Frueh L; Nilsen A; Pou S; Winter R; Riscoe MK; Shankar G
Pharm Dev Technol; 2020 Jun; 25(5):625-639. PubMed ID: 32031478
[TBL] [Abstract][Full Text] [Related]
17. Stabilising disproportionation of lipophilic ionic liquid salts in lipid-based formulations.
Lai A; Sahbaz Y; Ford L; Nguyen TH; Haque S; Williams HD; Benameur H; Scammells PJ; Porter CJH
Int J Pharm; 2021 Mar; 597():120292. PubMed ID: 33581479
[TBL] [Abstract][Full Text] [Related]
18. Orally administered self-emulsifying drug delivery system in disease management: advancement and patents.
Mishra V; Nayak P; Yadav N; Singh M; Tambuwala MM; Aljabali AAA
Expert Opin Drug Deliv; 2021 Mar; 18(3):315-332. PubMed ID: 33232184
[No Abstract] [Full Text] [Related]
19. Spray Drying as an Effective Method in the Development of Solid Self- Emulsifying Drug Delivery Systems.
Kumar M; Chawla PA; Faruk A; Chawla V
Curr Drug Deliv; 2023; 20(5):508-525. PubMed ID: 35578880
[TBL] [Abstract][Full Text] [Related]
20. Self-emulsifying drug delivery systems: a novel approach to deliver drugs.
Salawi A
Drug Deliv; 2022 Dec; 29(1):1811-1823. PubMed ID: 35666090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
